Assessment of GM-CSF receptors by real-time RT-PCR on cell lines expressing high and low affinity receptors and their relation to cytotoxic effect of chimeric protein (StxA1-GM-CSF)

Immunotoxins, which are composed of both the cell targeting and the cell killing moieties are the new approach for targeted therapy of human disease .In all immunotoxins that GMCSF has been used as cell targeting; only cell lines expressing high affinity receptor have been used for cytotoxicity studies. In the present study, various cell lines expressing high and low affinity receptors were used for assessment of the cytotoxic effect of hybrid chimeric protein. The expression of GM-CSF receptor (GM-CSFR) was quantified by realtime RT- PCR. The cell lines K562 and THP1 expressing high affinity receptor and MC-7, PC-3 and DU145 expressing low affinity receptor were used for this study. The chimeric hybrid protein was found to be toxic for various cell lines used in this investigation and cytotoxicity was more effective in cell lines bearing high affinity receptors. Overall, our results showed that the recombinant hybrid protein could have wide range of application on various cancer cell lines even cells bearing low affinity receptors for GM-CSF.

[1]  S. Bouzari,et al.  Selective cytotoxicity of recombinant STXA1-GM-CSF protein in hematopoetic cancer cells , 2006, Cell Biology and Toxicology.

[2]  Y. Kuwahara,et al.  Recombinant hybrid protein, Shiga toxin and granulocyte macrophage colony stimulating factor effectively induce apoptosis of colon cancer cells. , 2006, World journal of gastroenterology.

[3]  N. Shahrokhi,et al.  Expression of a Chimeric Protein Containing the Catalytic Domain of Shiga-Like Toxin and Human Granulocyte Macrophage Colony-Stimulating Factor (hGM-CSF) in Escherichia coli and Its Recognition by Reciprocal Antibodies , 2005 .

[4]  Yu Yang,et al.  [Expression and significance of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer]. , 2004, Zhonghua nan ke xue = National journal of andrology.

[5]  R. Pagano,et al.  Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11. , 2004, Molecular biology of the cell.

[6]  Y. Reiter Recombinant immunotoxins in targeted cancer cell therapy. , 2001, Advances in cancer research.

[7]  P. Quesenberry,et al.  Expression and function of colony‐stimulating factors and their receptors in human prostate carcinoma cell lines , 1998, The Prostate.

[8]  M. Willingham,et al.  Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein. , 1997, Blood.

[9]  I. Pastan,et al.  Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. , 1997, Blood.

[10]  G. Wagemaker,et al.  Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. , 1994, Blood.

[11]  K. Miyazono,et al.  Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. , 1990, Cell regulation.

[12]  K. Miyazono,et al.  Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor. , 1990, Leukemia.

[13]  M. Koyama,et al.  An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.

[14]  L. Reijnders,et al.  Gel electrophoresis of RNA under denaturing conditions. , 1973, Biochimica et biophysica acta.